1/25. Berdazimen- (ZELSUVMI)- (Jan 2024) to treat
Drug Name:
1/25. Berdazimen- (ZELSUVMI)- (Jan 2024) to treat
List Of Brands:
Indication Type Description:
Indication:
U.S. APPROVED DRUGS DURING 2023
Serial No 8
Name- SKYCLARYS
Acive Ingredient - Omvaeloxone
Pharmacological clssificiation- To treat Friedrich's Ataxia Date of Approval- 2/28/2023